These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3162437)

  • 1. Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancer.
    Haisma HJ; Moseley KR; Battaile AI; Griffiths TC; Zurawski VR; Knapp RC
    Int J Cancer Suppl; 1988; 2():109-13. PubMed ID: 3162437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of radiolabelled F(ab')2 fragments of monoclonal antibodies in nude mice bearing intraperitoneally growing human ovarian cancer xenografts.
    Moseley KR; Battaile A; Knapp RC; Haisma HJ
    Int J Cancer; 1988 Sep; 42(3):368-72. PubMed ID: 3417365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer.
    Haisma HJ; Battaile A; Stradtman EW; Knapp RC; Zurawski VR
    Int J Cancer; 1987 Dec; 40(6):758-62. PubMed ID: 3480271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and pharmacokinetics of radiolabeled monoclonal antibody OC 125 after intravenous and intraperitoneal administration in gynecologic tumors.
    Haisma HJ; Moseley KR; Battaile A; Griffiths TC; Knapp RC
    Am J Obstet Gynecol; 1988 Oct; 159(4):843-8. PubMed ID: 3177533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
    Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
    Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a radioiodinated monoclonal antibody F(ab')2 fragment in a xenograft model with circulating antigen.
    Zalutsky MR; Bast RC; Knapp RC
    Int J Rad Appl Instrum B; 1989; 16(4):405-11. PubMed ID: 2777582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.
    Thédrez P; Saccavini JC; Nolibé D; Simoen JP; Guerreau D; Gestin JF; Kremer M; Chatal JF
    Cancer Res; 1989 Jun; 49(11):3081-6. PubMed ID: 2720666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of radiolabelled anti-CA125 monoclonal antibody OC125-F(ab)2-fragment following resection guided by antibodies (REGAJ) in ovarian cancer patients.
    Uttenreuther-Fischer MM; Feistel H; Wolf F; Jäger W
    J Clin Lab Anal; 1997; 11(2):94-103. PubMed ID: 9058243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cytotoxicity of 131I-labelled OC125 F(ab')2 on human epithelial ovarian cancer cell lines.
    Schneider-Gädicke E; Humm JL; Lau CC; Macklis RM; Bastert G; Knapp RC
    Radiother Oncol; 1992 Mar; 23(3):150-9. PubMed ID: 1574594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal 131I- and 90Y-labelled monoclonal antibodies for ovarian cancer: pharmacokinetics and normal tissue dosimetry.
    Stewart JS; Hird V; Snook D; Sullivan M; Myers MJ; Epenetos AA
    Int J Cancer Suppl; 1988; 3():71-6. PubMed ID: 3209303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoscintigraphy of recurrences of gynecologic carcinomas.
    Chatal JF; Fumoleau P; Saccavini JC; Thedrez P; Curtet C; Bianco-Arco A; Chetanneau A; Peltier P; Kremer M; Guillard Y
    J Nucl Med; 1987 Dec; 28(12):1807-19. PubMed ID: 3500284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization.
    Del Vecchio S; Camera L; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M
    Int J Rad Appl Instrum B; 1991; 18(1):85-7. PubMed ID: 2010311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
    Gerretsen M; Quak JJ; Suh JS; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1991 Jan; 63(1):37-44. PubMed ID: 1989663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration.
    Buijs WC; Tibben JG; Boerman OC; Molthoff CF; Massuger LF; Koenders EB; Schijf CP; Siegel JA; Corstens FH
    Eur J Nucl Med; 1998 Nov; 25(11):1552-61. PubMed ID: 9799353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients.
    Hnatowich DJ; Griffin TW; Kosciuczyk C; Rusckowski M; Childs RL; Mattis JA; Shealy D; Doherty PW
    J Nucl Med; 1985 Aug; 26(8):849-58. PubMed ID: 3861793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.
    Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
    Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody.
    Zalutsky MR; Knapp RC; Bast RC
    Int J Rad Appl Instrum B; 1988; 15(4):431-7. PubMed ID: 3255739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18, reactive with an ovarian cancer-associated antigen.
    Molthoff CF; Buist MR; Kenemans P; Pinedo HM; Boven E
    J Nucl Med; 1992 Nov; 33(11):2000-5. PubMed ID: 1432162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancer.
    Finstad CL; Lloyd KO; Federici MG; Divgi C; Venkatraman E; Barakat RR; Finn RD; Larson SM; Hoskins WJ; Humm JL
    Clin Cancer Res; 1997 Aug; 3(8):1433-42. PubMed ID: 9815829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.